Annexon Biosciences (NASDAQ: ANNX) saw a significant pre-market surge of 44% following the announcement of positive topline results from their…
Read More »Biotech
Structure Therapeutics (NASDAQ: GPCR) has seen a significant surge in pre-market trading, driven by several key factors that have captivated…
Read More »Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company, saw its stock price surge significantly today despite the absence of any…
Read More »Immunovant, a clinical-stage biopharmaceutical company, has been making headlines with recent insider trading activities, SEC filings, and analyst opinions. This…
Read More »Predictive Oncology (NASDAQ: POAI) has seen a significant surge in its stock price, driven by the announcement of positive results…
Read More »Insmed (NASDAQ: INSM) has recently been in the spotlight following a significant surge in its stock price. This rise is…
Read More »ELEVAI Labs (NASDAQ: ELAB), a pioneering force in medical aesthetics, announced that Chief Executive Officer Dr. Jordan R. Plews, PhD…
Read More »Bicycle Therapeutics Plc (NASDAQ: BCYC) is making headlines with a significant pre-market surge, driven by a series of strategic moves…
Read More »ELEVAI Labs (NASDAQ: ELAB), a pioneering force in medical aesthetics, reported its financial results for the first quarter ended March…
Read More »Tesla (NASDAQ: TSLA) and SpaceX CEO Elon Musk has sparked a conversation about childhood obesity and potential solutions after giving…
Read More »